OpenEvidence, The ChatGPT For Doctors, Raises $200M At $6B Valuation
OpenEvidence, the ChatGPT for doctors, raises $200M at $6B valuation — a major leap for AI in healthcare. The fast-growing medical AI startup continues to attract investors eager to back tools that bring verified medical knowledge directly to clinicians’ fingertips.
Image Credits:OpenEvidence
A Powerful AI Assistant For Medical Professionals
Often compared to ChatGPT but designed specifically for medicine, OpenEvidence helps doctors and nurses find accurate clinical answers in seconds. The platform is trained on trusted medical journals such as JAMA and the New England Journal of Medicine, ensuring its insights are evidence-based and reliable.
Verified healthcare professionals can access OpenEvidence for free, supported by an ad-based model. The platform’s mission is to make advanced AI-driven medical knowledge accessible without compromising accuracy or trust.
Rapid Growth And Impressive User Adoption
Since its launch in 2022, OpenEvidence has seen tremendous growth. Monthly clinical consultations on the platform have nearly doubled to 15 million since July, highlighting its rising importance in hospital settings and clinical decision-making.
The company’s rapid adoption mirrors the growing trend of AI specialization — where models like OpenEvidence are tailored for specific industries rather than general use.
Investor Confidence Continues To Surge
The $200 million funding round comes just three months after OpenEvidence raised $210 million at a $3.5 billion valuation. The latest investment, doubling its valuation to $6 billion, signals strong investor confidence in the company’s vision and scalability.
Leading the new round was Google Ventures, joined by top firms including Sequoia Capital, Kleiner Perkins, Blackstone, Thrive Capital, Coatue Management, Bond, and Craft. Their participation underscores a clear belief that domain-specific AI models are the future of enterprise-grade artificial intelligence.
Transforming The Future Of AI In Healthcare
OpenEvidence’s success showcases how AI is reshaping the medical field — from diagnosis support to treatment recommendations. By combining massive medical data with natural language understanding, the tool allows clinicians to make faster, more informed decisions.
As the platform scales, its creators aim to expand globally, integrate with hospital systems, and continue refining AI models to meet medical safety standards. The focus remains on enhancing human expertise, not replacing it.
With $200 million in fresh capital and a $6 billion valuation, OpenEvidence is well-positioned to redefine how healthcare professionals access and apply medical knowledge. Its continued momentum signals the rise of a new era where AI doesn’t just support daily workflows but elevates the standard of patient care worldwide.
إرسال تعليق